NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Atlys Secures $36 Million in Series C Funding

Atlys, a visa processing startup, has closed a $36 million Series C funding round led by Susquehanna Asia VC, with participation from existing investors Elevation Capital, Long Journey Ventures, and Peak XV Partners. MakeMyTrip also joined the round as a new investor.

Atlys sees strong growth in visa processing volumes, with a current annual visa run rate of 700,000+. Since its Series B round in 2024, the company has grown 11 times, processing nearly 450,000 visas. Atlys enables travellers to discover, apply for, and manage visas digitally across 120+ destinations.

The company plans to use the fresh capital to expand into new international markets and accelerate its AI roadmap, embedding intelligence across the visa lifecycle. Atlys aims to remove barriers that prevent people from exploring the world, making cross-border travel more reliable.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Founded by Mohak Nahta, Atlys has expanded across international markets, including the UAE, US, UK, and Australia, which now account for nearly half of its business. Prior to this round, Atlys raised its Series B funding in 2024 and has received funding from Peak XV Partners, Elevation Capital, Andreessen Horowitz, and South Park Commons.

Investor Takeaway

Investors should consider Atlys for its strong growth in visa processing volumes.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.